Drug GMP Inspections


Drug GMP Inspections: Common Deficiencies

Evidence to support significant and/or a trend of deficiencies within a system covered could demonstrate the failure of a system and will result in consideration of the issuance of a warning letter or other regulatory action by the FDA. Read More